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INTRODUCTION
Secondary Mitral Regurgitation:  
Definition and Classification
As opposed to primary mitral regurgitation (MR), which is 
characterized by morphologic abnormalities of the mitral 
valve, chronic secondary mitral regurgitation (SMR) is 
exclusively a disease of the left ventricle (LV) with direct 
consequences on mitral valve function. In chronic SMR, 
the mitral valve is morphologically intact. However, there 
is marked distortion of the mitral valve and subvalvular 
apparatus, due to regional or global LV remodeling that leads 
to valve incompetence during systole. 
Chronic SMR may develop in the context of ischemic 
(chronic ischemic MR) or non-ischemic heart disease 
(chronic non-ischemic MR). Irrespective of the scenario, LV 
remodeling (either local, either regional) is a prerequisite. 
Thus, the term “secondary” reflects the fact the valve 
dysfunction is only secondary to a left ventricular disease. 
While “ischemic” or “non-ischemic” secondary MR refers to 
SMR etiology.
This chapter will address the topic of chronic ischemic 
MR, by far the most frequently encountered entity. For 
further understanding of this chapter some additional 
term definitions are necessary. Other types of MR have 
been described and classified as “ischemic MR” the “acute 
ischemic MR” complicating an acute transmural myocardial 
infarction (MI) with rupture of the papillary muscle and the 
“transient ischemic MR” complicating a transient myocardial 
ischemic event (reversible myocardial ischemia involving 
the LV wall adjacent to the papillary muscles). As opposed 
to these entities, in chronic ischemic MR, there is progressive 
irreversible damage and remodeling of the LV, months to 
years, after a myocardial infarction (MI). 
MECHANISM AND PATHOPHYSIOLOGY 
The maintenance of perfect geometrical and functional 
balance between the MV apparatus and the LV throughout 
systole is the key to prevent any type of SMR, of either ischemic 
or non-ischemic etiology.
After MI and through a complex remodeling process, the 
LV can change its “bullet shape” geometry, becoming more 
spherical. This change in LV geometry may lead to apical and 
outward displacement of papillary muscles which, in turn, 
pulls on the mitral valve (MV) chordae and leaflets throughout 
the entire LV systole leading to tethering, restricted systolic 
leaflet motion and tenting of the leaflets (Figure 1). Systolic 
tethering of the MV leaflets brings the leaflet coaptation 
line more apically into the LV cavity and can decrease the 
coaptation surface, thus, leading to valve incompetence 
(Figure 2).1-3 
Classically, it has been hypothesized that the relative 
position of mitral leaflets coaptation line in SMR, depends on 
the balance between the forces that work to push the leaflets 
together and towards the base of the LV (i.e. closing forces) 
and the forces that pull them apart (pulling them towards the 
LV apex or sideways).1
Little force is needed to seal the normal MV in systole. 
However, in the presence of tethering, MV leaflet closure is 
further impaired by LV systolic dysfunction and a decrease in 
LV closing forces will favor MR, while preservation of closing 
forces will work to diminish MR severity.1,2,4,5 In patients with 
ischemic MR, “closing forces” typically refer to preservation 
of LV systolic function2 and intraventricular/interpapillary 
muscle synchrony,6,7 but also to the preservation of the 
geometry8 and “sphincteric” function9 (i.e reduction in 
annular circumference with systole, which in normal subjects 
is about 25%10) of the MV annulus. To note, significant 
SMR does not occur in patients with global LV systolic 
dysfunction without tethering.2,11 Otsuji et al. demonstrated 
that LV dilatation and remodeling was a prerequisite for MR 
development after MI and that isolated reduction in closing 
forces without LV dilatation led only to trace MR.2 Similarly, 
reduction of mitral annulus “sphincter function” (such as 
in patients with atrial fibrillation, dilated atria and dilated 
mitral annuli) did not lead to significant SMR in absence of 
regional/global LV remodeling.12 However, both mechanisms 
promoted SMR in the presence of tethering.
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Figure 1A and B: Systolic apical displacement of mitral leaflets and coaptation point relative to the annular plane (white dashed line) in a 
patient with ischemic dilated cardiomyopathy and ischemic MR; (B) as compared to a patient with normal LV geometry and function and 
without MR (A). LV, left ventricle. The red arrows designate the direction of displacement of the papillary muscles, the red dots indicate 
the coaptation point of the valve leaflets
Figure 2: Systolic tethering of the MV leaflets which brings the leaflet coaptation line more apically into the LV cavity. PPSLA, parasternal 
long-axis view; 4 CH, 4-chamber view. The yellow arrows indicate that the coaptation line of the MV leaflets are displaced apically; the 
blue dotted area underneath the MV leaflets represents the tenting created by the leaflet tethering
A B
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The MV leaflets enlargement that develops in the 
presence of chronic leaflet tethering may contribute to the 
reduction of MR severity in some patients10,13 and thus, can 
be categorized as part of the “closing force” mechanisms. In 
SMR, mitral leaflet area may increase by ≤35% on average 
but differs in individual patients for a comparable degree of 
leaflet tethering and LV remodeling.13 Thus, this adaptative 
mechanism, aiming to reduce leaflet tethering and improve 
coaptation, is sometimes overridden and SMR ensues. 
Conversely, “tethering forces” refer to all forces that 
through a complex interplay pull the leaflets apart during 
systole, preventing effective MV orifice closure. The key 
“tethering force” in chronic ischemic MR is the local or 
regional LV remodeling that leads to papillary muscle 
displacement. Mitral annular dilatation and loss of “saddle-
shape” geometry contribute to the development of SMR as an 
adjunctive mechanism.8,9 Similarly, the progressive increase 
in left atrial (LA) pressure may contribute to SMR by pushing 
the MV leaflets further apically and thus, aggravating valve 
incompetence.14 
The pathophysiology of chronic ischemic MR differs from 
the pathophysiology of organic MR in the sense that the former 
imposes a chronic increase in volume overload on an already 
sick ventricle, less able to cope with this supplementary load 
and very much in need to maintain its closing forces. A vicious 
circle is established in the presence of chronic ischemic MR, 
LV continues to dilate and remodel leading to a progressive 
increase in MV leaflet tethering and aggravating the MR and 
so on. Apart from the downstream consequences on the LV, 
ischemic MR leads to the progressive increase of pulmonary 
venous pressure, a phenomenon dependent on the degree 
of LA compliance. In most patients with chronic ischemic 
MR, LA progressively enlarges, and this is why, the increase 
in pulmonary venous pressure occurs late in the natural 
history of the disease. Once pulmonary venous pressure has 
increased, signs and symptoms of pulmonary congestions 
develop. Moreover, another vicious circle is closed, as the 
increase in LA pressure will contribute to the worsening of 
chronic ischemic MR and to further increase in pulmonary 
venous pressure. 
ECHOCARDIOGRAPHIC DIAGNOSIS
First step to the echocardiographic diagnosis of chronic 
ischemic MR is to suspect this entity in each patient with 
regional or global LV remodeling, then to try to identify what 
are the mechanisms involved in its genesis. Systolic apical 
displacement of mitral leaflets and coaptation line is the key 
change in mitral apparatus geometry (Figures 1 and 2) and the 
easiest feature that can be identified by echocardiography.15,16 
Two patterns of leaflet tethering have been classically 
described—symmetric and asymmetric. 17 If both papillary 
muscles are displaced apically and outward, both MV leaflets 
are equally tethered (i.e. symmetric tethering) and a typically 
central MR jet can be seen. Otherwise, when only one of the 
two papillary muscles is displaced, tethering is predominant 
on one of the leaflets, usually the posterior leaflet (Figure 
3B). This leads to asymmetric apposition of the two leaflets 
over the length of a segment of the coaptation surface and to 
an eccentric MR jet. Commonly, the posteromedial papillary 
muscle displacement, as in inferior and inferolateral wall 
myocardial infarction, will create an asymmetric tethering 
pattern with severe tethering on the posteromedial scallop 
of the posterior leaflet (P3), asymmetric apposition of the 
leaflets at the level of this scallop, and an eccentric, posterior 
oriented MR jet. Hence, analyzing jet direction by color flow 
Doppler in patients with chronic ischemic MR can give useful 
hints about the type of tethering and is an important step in 
the analysis of MR mechanism (Figure 3).
The next step in the complete diagnosis of chronic ischemic 
MR is the quantification of MR severity. It is mandatory to 
quantify chronic ischemic MR severity by echocardiography, 
as a graded relationship between ischemic MR severity and 
reduced survival has been demonstrated.18 Quantitative and 
semiquantitative methods can be used to determine the 
severity of chronic ischemic MR. Semiquantitative methods, 
such as vena contracta width and regurgitant jet area, are of 
little interest due lower accuracy in eccentric jets and too 
poor reproducibility, respectively.19 Quantitative methods, 
such as the Doppler volumetric method and the proximal 
isovelocity surface area (PISA) method can grade MR severity 
accurately.20,21 The Doppler volumetric method allows the 
calculation of regurgitant volume (RV) as the difference 
between mitral and aortic stroke volumes.20 It is rarely 
performed in the clinical setting because it is time consuming, 
needs several cumbersome manual measurements, and 
small errors may lead to significant inaccuracies. The PISA 
method allows the quantification of both RV and effective 
regurgitant orifice area (EROA).21 The PISA method has 
several limitations that should be acknowledged.22 First of all, 
the PISA radius changes during systole, being larger in early 
and late systole and smaller in midsystole.23 Performing only 
one measurement in midsystole will lead to underestimation 
of EROA and RV. Ideally, the PISA radius should be averaged 
throughout systole, but software capable of performing 
such a measurement has not been yet developed. Second, 
the PISA method assumes that the flow convergence area 
is hemispherical. In practice, flow convergence area is 
frequently hemielliptic, especially in chronic ischemic 
MR, and applying the PISA method in this case will lead 
to underestimation of EROA and RV.24,25 Real-time 3D 
echocardiography may be a solution to this problem, but large 
outcome studies are still missing. The problem of multiple 
jets could be also solved by this particular technique. 3D 
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echocardiography, both transthoracic and transoesophageal, 
allows measurement of color-Doppler based vena contracta 
area.26 A 3D derived VC area of ≥0.41 cm² seems to indicate 
severe ischemic MR. However, further validation of this cutoff 
value is necessary.27 A more recent and promising technique 
developed to quantify MR severity, that could be applied to 
chronic ischemic MR quantification, is 3D derived proximal 
isovelocity surface area (3D PISA). It allows computation of 
a peak 3D effective regurgitant orifice area (3D-EROA) from 
the peak regurgitant jet velocity (as assessed by continuous 
wave (CW) Doppler) and the direct 3D based measurement 
(without any geometrical assumption) of the PISA.28 
However, as for the VC area, validation and outcome studies 
are still needed. To everyday clinical practice and for the time 
being, 2D derived EROA and RV using the PISA method or 
the Doppler volumetric, are the methods recommended to 
quantify chronic ischemic MR19 and decision-making is still 
based on these 2D echocardiography derived cutoff values. 
Severe ischemic MR is defined as an EROA >20 mm² or a RV 
>30 mL.18,19
Another important step in the echocardiographic 
evaluation of chronic ischemic MR, with important impli-
cations with regard to treatment strategies, is the assessment 
of mitral valve configuration. With 2D echocardiography the 
following parameters can be measured to assess the degree of 
deformity of the mitral valve apparatus: annular dimensions, 
tenting area (area of the region enclosed between the annular 
plane and the mitral leaflets), anterior and posterior leaflets 
angle (Figure 4A), coaptation distance (shortest distance 
between the mitral annulus plane and the leaflet coaptation 
point), bending distances and coaptation length.29 Frequently 
used in clinical practice and with prognostic implications are 
tenting area, coaptation distance, posterior leaflet angle, and 
mitral annulus diameter. An MV tenting area ≥2.5 cm² or ≥1.6 
cm,² a coaptation distance ≥1 cm, a posterior leaflet angle 
≥45° and an annulus diameter ≥37 mm predict persistence 
of MR after restrictive annuloplasty.30,31 These measurements 
are usually performed in apical 4-chamber view (Figure 4A) 
in mid-systole with the exception of mitral annulus diameter 
in which the cutoff value was obtained from transesophageal 
echocardiography in diastole.
Three-D echocardiography is able to provide all the 
above-mentioned measurements with better accuracy, 
because the technique reduces the risk of measurements 
performed in off-axis planes. However, the major limitation 
is the dependency on image quality. Mitral annular geometry 
and dynamics are best assessed by 3D echocardiography.8 
Mitral annular reconstruction is available using commercial 
software by off-line analysis of the acquired 3D dataset. 
Annular diameter and area are increased, the annulus is 
less elliptical and more flattened, and there is a decrease 
in annular “sphincter” function in patients with SMR as 
compared to normal subjects.8 Tenting volume, the volume 
enclosed between the surface of the mitral leaflets and 
the annular plane, can be computed from the 3D datasets 
through off-line analysis with dedicated software. This 
parameter proved to be closely related to SMR severity and 
a reliable marker of leaflets tethering severity.32 With 3D 
echocardiography, leaflet surface area, leaflet area/closure 
area and leaflet area/annular area ratios can be assessed. 
Figure 3A and B: Depending on which leaflet is predominantly tethered the direction of the regurgitant jet changes “pointing out” 
the leaflet that is more severely tethered. (A) Severe tethering of the anterior mitral leaflet with an eccentric jet (asymmetric tethering 
pattern) towards the interatrial septum; (B) Severe tethering of the posterior leaflet with an eccentric jet towards the posterior atrial wall 
(asymmetric tethering pattern).
A B
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Figure 4A to C: Echocardiographic evaluation of a patient with 
dilated cardiomyopathy and secondary MR. (A) Coaptation 
distance (CD) measures 1.0 cm, the posterior leaflet length (PLL) 
measures 1.7 cm. Thus, the posterior leaflet angle (PLA) can be 
calculated applying the formula PLA = sin–1(CD/PLL) = 36°. In 
this case a CD of 1.0 cm is a predictor of MR persistence after 
annuloplasty. Moreover, the mitral annulus measures 4.7 cm (>3.7 
cm) and is also a predictor of persistence of MR after restrictive 
annuloplasty. (B) Interpapillary muscle distance measured at end-
systole is 4.5 mm (>2.0 cm). (C) Sphericity index (LV short-axis to 
long-axis diameter ratio measured at end-systole) is 0.85 (>0.7). 
Both the interpapillary muscle distance and the sphericity index 
predict the recurrence of MR after undersized annuloplasty in this 
patient.
Leaflet surface area proved to increase by at least 35% on 
average in patients with SMR,13 while leaflet area/closure 
area and leaflet area/annular area ratios are lower in patients 
with significant SMR.33 Their incremental role compared to 
2D echocardiography in predicting outcome after treatment 
in patients with chronic ischemic MR is still undefined.
Last but not the least, echocardiography helps in the 
evaluation of LV remodeling in patients with chronic ischemic 
MR. The following parameters need to be reported: LV 
volumes, LV ejection fraction, wall motion abnormalities, LV 
systolic sphericity index (LV short axis-to-long axis diameter 
ratio measured at end-systole) (Figure 4C), the interpapillary 
muscle distance (the length between the papillary muscles in 
short axis view at end-systole) (Figure 4B) and the tethering 
distance (the distance between the intervalvular fibrosa 
and the head of the posteromedial papillary muscle at mid-
systole). All of these parameters can be measured with 2D 
echocardiography and the cutoff values with prognostic 
implications have been reported from 2D echocardiographic 
studies, but they can be obtained by 3D echocardiography 
with the advantage of lower variability of measurement. An 
LV end-systolic volume ≥145 mL, a systolic sphericity index 
≥0.734,35 and an interpapillary muscle distance >20 mm 
measured at end-systole using 2D echocardiography perform 
well in predicting recurrent MR after undersized annuloplasty 
for chronic ischemic MR.36
DYNAMIC NATURE
Role of Stress Echocardiography
Chronic ischemic MR has a dynamic nature.37 Its severity 
varies throughout systole, with a decrease of severity in mid-
systole that parallels the increase in LV closing forces.23 Yet, 
its dynamic nature is best highlighted by the change in SMR 
severity with different loading conditions. One of the classical 
examples of preload and afterload dependency of SMR 
severity was given by Levine et al. who described the vanishing 
of MR intraoperatively (preload and afterload reduction 
concomitant with increase in contractility due to inotropic 
agents) in patients with ischemic MR undergoing coronary 
bypass grafting (CABG).37 In our experience, exercise stress 




16.indd   5 12-03-2016   13:52:57
6 Section 2 Clinical Applications
the dynamic behavior of chronic ischemic MR. Exercise 
alters the loading conditions of the LV by modifying preload, 
afterload and contractility, and if an exercise test is performed 
parallel to imaging of the LV and Doppler interrogation of 
the MV, the mechanisms involved in the dynamic behavior 
of chronic ischemic MR can be revealed in each individual 
patient. An ESE is able to provide prognostic information over 
resting echocardiography, by unmasking patients at high-risk 
of poor outcome 38,39 and allows matching of MR severity with 
symptom development.39 An exercise-induced increase in 
EROA by ≥13 mm² proved to be a predictor of mortality and 
of hospital admission for heart failure in patients with SMR 
(Figure 5).38
The most recent guidelines of the European Society 
of Cardiology (ESC) on the management of valvular heart 
disease emphasize that “the dynamic component of SMR can 
be assessed and quantified by exercise echocardiography” 
and that “in patients capable of exercising, exercise 
echocardiography should be considered whenever possible” 
in patients planned for surgical revascularization.40 
Based on our experience, exercise stress echocardiography 
may be of interest in the following categories of patients: (i) in 
patients with LV dysfunction who present exertional dyspnea 
out of proportion to the severity of resting LV dysfunction or 
MR severity, (ii) in patients in whom acute pulmonary edema 
occurs without any obvious cause, (iii) to unmask patients at 
high-risk of mortality and heart failure, (iv) before surgical 
revascularization in patients with moderate ischemic MR, and 
(v) following surgery, to identify persistence of pulmonary 
hypertension and explain the absence of functional class 
improvement.
An ESE requires a dedicated tilting table, continuous 
electrocardiographic monitoring facilities, advanced life 
support facilities, and medical personnel with adequate 
expertise in the field. A symptom limited and gradual exercise 
test (workload increase by 25 watts each 2 minutes) is 
recommended. In the absence of symptoms the test should be 
continued until 85% of the age predicted heart rate is reached. 
The test should not be performed in NYHA class IV patients, 
in patients with uncontrolled blood pressure values at rest 
(systolic arterial pressure >200 mm Hg or diastolic arterial 
pressure >110 mm Hg), in symptomatic patients or patients 
with uncontrolled arrhythmias or unable or unwilling to 
perform such a test.
A complete resting echocardiography is performed at rest, 
prior to exercise. Image acquisition both at rest and during 
exercise is done with the patient on a tilting table located 
on the left side of the sonographer. Throughout each step of 
the test the following imaging sequence is recommended to 
be recorded: CW Doppler imaging of the tricuspid valve for 
assessment of peak systolic trans-tricuspid gradient, pulsed-
wave Doppler at the level of the mitral leaflet tips for the LV 
inflow profile, at the level of the mitral annulus and of the LV 
outflow tract for stroke volume calculation, color Doppler 
imaging of the mitral valve for PISA radius measurement, CW 
Doppler imaging of the MR jet and gray scale loops focused 
on the LV in apical 4-, 2- and 3-chamber view.
During ESE the following questions should find an 
answer: (i) what happens with the MR: does it increase/
decrease or remains unchanged? (ii) does the tethering on 
MV increase/decrease or remains unchanged? (iii) are there 
new wall motion abnormalities or is there a recruitment of 
the hibernating myocardium? (iv) is there a significant and 
rapid increase in systolic pulmonary artery pressure with 
exercise? and (v) what is the mechanism of MR behavior 
during exercise: a decrease in closing forces or an increase in 
tethering of the MV?
Figure 5A and B: Dynamic trait of ischemic MR with decrease in MR severity in mid-systole as compared to early and late systole [the 
arrow indicated that in mid-systole the PISA radius is decreasing as compared to early and late systole (A)] and increase in MR severity 
during exercise stress echocardiography [more than 13 mm² exercise-induced increase in EROA in a patient with ischemic MR (B)].
A B
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TIMING AND PATIENT SELECTION FOR 
SURGICAL CORRECTION 
Even though the survival benefit of MV repair compared to 
myocardial revascularization alone has not been proven in 
randomized studies, the association of chronic ischemic 
MR with poor outcome and the fact that myocardial 
revascularization alone does not correct MR supports MV 
surgery at the time of surgical revascularization in patients 
with indication for CABG and moderate or severe chronic 
ischemic MR.40 Because of a lower mortality rate, MV repair 
is preferred over MV replacement (6.8% vs. 11.4% when 
combined with CABG, Fourth European Association for 
Cardio-Thoracic Surgery (EACTS) adult cardiac surgical 
database report 2010). According to current guidelines, 
MV surgical repair is indicated in patients with severe MR 
and LV ejection fraction >30% undergoing CABG, as it 
should be considered in moderate MR, especially if there is 
a high likelihood of reparability or if a significant dynamic 
component (i.e. increase in EROA with exercise by ≥13 
mm²) is documented with ESE.40 In patients without a clear 
indication for revascularization, the assessment of myocardial 
viability and coronary status is mandatory to guide treatment. 
Symptomatic patients with severe chronic ischemic MR, LV 
ejection fraction less than 30%, option for revascularization 
and evidence of myocardial viability should benefit from 
MV repair. In contrast, symptomatic patients with severe 
ischemic MR, LV ejection fraction >30%, without possibility 
of myocardial revascularization, but with low comorbidity, 
should be operated only if they remain symptomatic despite 
optimal medical treatment. For others, medical treatment or 
cardiac transplantation is preferred.40
The most common surgical technique to correct chronic 
ischemic MR is restrictive annuloplasty. Even though chronic 
ischemic MR is a ventricular and not a valvular disease, 
and that MV repair using restrictive annuloplasty targets 
the consequences rather than the cause of the disease, this 
technique is still largely used and provides good results 
in terms of MR correction and improvement of symptoms 
in well-selected patients. However, its major drawbacks 
are related to the risk of significant residual (persistent or 
recurrent) MR following MV repair with this technique.
Persistent MR after MV repair (i.e. MR seen immediately 
after surgery) can be explained by the reduction of the 
anteroposterior annular diameter due to the rigid ring that 
leads to anterior displacement of the posterior annulus 
and further tethering of the posterior leaflet.35 Usually, MR 
jet is eccentric in this case and oriented posteriorly. On 
the other hand, recurrent MR is more related to ongoing 
LV remodeling happening progressively after surgery, with 
increasing LV volume and sphericity, further tethering of 
both leaflets and MR. Usually, in this case, MR jet tends to be 
more frequently central. Preoperative evaluation of tethering 
with echocardiography can help to detect patients at risk of 
persistent or recurrent MR. Asymmetrical tethering pattern, 
predominant posterior leaflet tethering, is associated with 
localized LV remodeling and higher risk of persistent MR. In 
contrast, symmetrical pattern, explained by predominant 
apical tethering of both leaflets, is associated with lack of 
reverse LV remolding after revascularization and higher risk 
of recurrent MR.
Several studies attempted to identify the preoperative 
predictors of MV repair failure. Prediction of persistent MR is 
based on MV geometry assessment, such as MV tenting area 
≥2.5 cm2 or ≥1.6 cm2, coaptation distance ≥1 cm, posterior 
leaflet angle ≥45o and annulus diameter ≥37 mm.30,31 An 
increased posterior leaflet angle was the best predictor of 
persistent MR and associated with a markedly reduced 
3-year event-free survival in one study.30 Recurrent MR is 
better predicted by LV remodeling parameters such as LV 
end-systolic volume ≥145 mL, systolic sphericity index 
≥0.734,35 and an interpapillary muscle distance >20 mm.36 
However, the presence of significant tethering does not 
preclude annuloplasty if the patients fulfill the ESC criteria 
for revascularization and valve repair. However, in patients 
with high-risk of MV repair failure, MV replacement 
with preservation of the subvalvular apparatus could be 
contemplated.
Surgical or interventional techniques, addressing the 
ventricular problem (ventricular plication, polymer injection 
to reverse myocardial remodeling) or addressing the 
subvalvular apparatus (secondary chord cutting, repositioning 
of the papillary muscles) showed promising results but have 
not yet been accepted by current guidelines.41-43 
Further studies are needed to conclude on the best 
therapeutic approach to improve outcomes in patients with 
significant chronic ischemic MR and at high-risk of residual 
MR after MV restrictive annuloplasty. 
CONCLUSION
Chronic secondary MR is common after MI and/or in 
patients with dilated cardiomyopathy. Prompt recognition of 
the mechanism and etiology is highly important, as severity 
grading is different from organic MR. Echocardiography is 
the key investigation to make the diagnosis, assess severity, 
and its consequences on the LA, LV and pulmonary vascular 
bed. Based on our experience, an approach to a patient with 
chronic ischemic MR can be summarized in Flow chart 1.
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